PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+30.09%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.25B
AUM Growth
+$1.25B
(+12%)
Cap. Flow
-$74.5M
Cap. Flow
% of AUM
-5.97%
Top 10 Holdings %
Top 10 Hldgs %
50.46%
Holding
196
New
50
Increased
30
Reduced
37
Closed
40
Top Buys
| 1 |
uniQure
QURE
|
$20.5M |
| 2 |
Travere Therapeutics
TVTX
|
$20.2M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$18.2M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$12.5M |
| 5 |
CEMP
Cempra, Inc.
CEMP
|
$11.2M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$34.8M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$28.5M |
| 3 |
Esperion Therapeutics
ESPR
|
$26.7M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$19.3M |
| 5 |
AGN
ALLERGAN INC
AGN
|
$17.6M |
Sector Composition
| 1 | Healthcare | 82.46% |
| 2 | Technology | 0.06% |
| 3 | Financials | 0.04% |
| 4 | Energy | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $157M | 12.21% | 14,439,444 | – | – |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $149M | 11.55% | 3,741,267 +176,000 | +5% | +$6.99M |
|
|
3
Travere Therapeutics
TVTX
$1.56B
| $66.7M | 5.19% | 2,784,980 +844,255 | +44% | +$20.2M |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $56.2M | 4.36% | 978,359 +95,000 | +11% | +$5.45M |
|
|
RLYP
5
DELISTED
RELYPSA INC COM
RLYP
| $52.5M | 4.08% | 1,454,142 +215,000 | +17% | +$7.76M |
|
6
Iovance Biotherapeutics
IOVA
$807M
| $32.9M | 2.55% | 2,714,549 -500,000 | -16% | -$6.05M |
|
7
Xencor
XNCR
$580M
| $29.9M | 2.33% | 1,954,785 +27,614 | +1% | +$423K |
|
|
DYAX
8
DELISTED
DYAX CORPORATION
DYAX
| $29.8M | 2.31% | 1,777,000 -75,000 | -4% | -$1.26M |
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $29.3M | 2.28% | 2,204,652 -607,700 | -22% | -$8.07M |
|
|
NVRO
10
DELISTED
NEVRO CORP.
NVRO
| $26.7M | 2.07% | 557,056 +380,493 | +215% | +$18.2M |
|
11
Talphera
TLPH
$11.1M
| $25.4M | 1.97% | 6,574,060 | – | – |
|
|
12
uniQure
QURE
$896M
| $25.2M | 1.96% | 1,039,332 +843,476 | +431% | +$20.5M |
|
|
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $24.2M | 1.88% | 1,046,402 | – | – |
|
|
ARAV
14
DELISTED
Aravive, Inc. Common Stock
ARAV
| $24.2M | 1.88% | 1,546,471 +615,300 | +66% | +$9.61M |
|
15
Zimmer Biomet
ZBH
$21B
| $21.2M | 1.65% | 180,793 +26,700 | +17% | +$3.14M |
|
|
CEMP
16
DELISTED
Cempra, Inc.
CEMP
| $19.6M | 1.53% | 572,500 +325,000 | +131% | +$11.2M |
|
|
RCPT
17
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $19.6M | 1.52% | 118,794 -172,600 | -59% | -$28.5M |
|
18
Acadia Pharmaceuticals
ACAD
$4.38B
| $19.6M | 1.52% | 600,240 -493,041 | -45% | -$16.1M |
|
19
ANI Pharmaceuticals
ANIP
$2.03B
| $19.3M | 1.5% | 307,784 -4,716 | -2% | -$295K |
|
|
OTIC
20
DELISTED
Otonomy, Inc.
OTIC
| $17M | 1.32% | 480,387 +26,081 | +6% | +$922K |
|
|
BLUE
21
DELISTED
bluebird bio
BLUE
| $16.3M | 1.27% | 135,000 -90,000 | -40% | -$10.9M |
|
22
Sonida Senior Living
SNDA
$488M
| $15.7M | 1.22% | 605,000 +355,000 | +142% | +$9.21M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $14.6M | 1.14% | 49,185 +34,097 | +226% | +$10.1M |
|
|
PFNX
24
DELISTED
Pfenex Inc.
PFNX
| $13.8M | 1.07% | 866,423 +461,758 | +114% | +$7.36M |
|
|
PTLA
25
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $13.5M | 1.05% | 355,000 +330,000 | +1,320% | +$12.5M |
|